FDA's top drug regulator quits
Digest more
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...
Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.
Six people have died and 25 people have been hospitalized due to a listeria outbreak linked to now-recalled precooked pasta ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
Novo Nordisk narrowed its earnings guidance as intensifying competition, pricing pressure and copycat versions of its ...
The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive ...
Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
Shares of Biohaven fell more than 40% on Wednesday after the U.S. Food and Drug Administration declined to approve its experimental treatment for a rare brain disorder.
New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback